News Search Results
Jan 07, 2026, 07:00 ET AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15
investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1) designed to inhibit the spread of SOD1 pathology in the CNS of ALS patients. AP-101 received orphan drug designations from FDA, EMA and Swissmedic. The Phase 2 study evaluated safety, tolerability, pharmacodynamic
More news about: AL-S Pharma AG
Jan 06, 2026, 19:00 ET コーヘン&スティアーズ・ジャパン代表取締役社長に白勢菊夫を任命
https://www.cohenandsteers.comティッカー：NYSE: CNS将来の見通しに関する記述について本プレスリリースおよびコーヘン&スティアーズが行うその他の記述には、1933年証券法（改正後）第27A条および1934年証券取引所法（改正後）第21E上の意義の範囲内における将来の見通しに関する記述が含まれている場合
More news about: Cohen & Steers, Inc.
Jan 06, 2026, 08:01 ET TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
already been completed and that the formulation has shown appreciable safety in Phase I clinical trials in patients with non-central nervous system (CNS) cancers, these results support advancing TTX-MC138 to future clinical evaluation in patients with GBM."This research represents an important
More news about: TransCode Therapeutics, Inc.
Jan 06, 2026, 06:28 ET Election Results for 2026 NCC Board of Directors and Officers
3rd EditionNCC CertificationNeonatal Neuro-Intensive Care (C-NNIC), 2020 – PresentJean Salera, DNP, PNS, APRN-CNS, RNC-OB, C-EFM, C-ONQS, was elected to the Board of Directors. Ms. Salera is the Associate Chief Nursing Officer, Professional Development at Women
More news about: National Certification Corporation
Jan 06, 2026, 05:00 ET Cumulus Neuroscience Publishes Data Validating a Scalable Measurement of Neuroplasticity Using Low-Burden Dry Sensor EEG
assessment can be employed across multiple clinical trial sites as an objective measure of neuroplastic modulation in real-world clinical trials of CNS therapies BELFAST, Northern Ireland, Jan. 6, 2026 /PRNewswire/
More news about: Cumulus Neuroscience
Jan 02, 2026, 13:00 ET Board of Certification for Emergency Nursing Announces 2026-2027 Board of Directors
freestanding emergency department, Kadlec Regional Medical Center, Kennewick, WashingtonImmediate Past Chairperson: Allen C. Wolfe Jr., MSN, CNS, APRN, CFRN, CCRN, CTRN, TCRN, CMTE, FAASTN, senior director of clinical education, Life Link III, Bloomington, MinnesotaReturning Members-at-large:
More news about: Board of Certification for Emergency Nursing
Jan 01, 2026, 01:00 ET ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
possibleBBB penetrating ELP (Elastin-Like Polypeptide) platform: BBB shuttle platform fusing ELP to make monthly CNS drugsPF1801 (Polymyositis/Dermatomyositis, DMD & Sarcopenia): Currently
More news about: ImmunoForge
Dec 30, 2025, 04:00 ET Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO
programs centered around key therapeutic areas including fibrosis, oncology, immunology, inflammation, cardiometabolics and central nervous system (CNS) disease. Among all the innovative pipelines, 10 have received IND clearance, 7 of them are currently in active clinical development.Meanwhile,
More news about: Insilico Medicine
Dec 22, 2025, 09:00 ET LongueVue Capital Invests in Saelens
advanced manufacturing facilities in Wisconsin and serves customers under the trade names Diamond Precision Products ("DPP") and Coupling Nut Supply ("CNS"). The Company also provides international sourcing and manufacturing services through its subsidiary, Lembak Global Sourcing ("Lembak"). After doubling
More news about: LongueVue Capital
Dec 19, 2025, 08:43 ET Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson's and Alzheimer's Diseases
Mercury Bio's CNS therapeutics."This partnership allows us to evaluate disease mechanisms and therapeutic hypotheses in a context that has historically been inaccessible," said Lee Sherlock, Chief Executive Officer of Meta-Flux. "By applying our modeling framework to Mercury Bio's CNS programs, we
More news about: Mercury Bio Inc. & Meta-Flux
Dec 19, 2025, 07:44 ET Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
obe-cel can produce high remission rates in this pediatric patient population, including in patients with high-risk relapse and patients with primary CNS relapse. Consistent with our experience in the adult population, data show low rates of severe CRS and ICANS."Autolus also presented post-hoc
More news about: USA News Group
Dec 19, 2025, 03:00 ET The CHMP adopted a positive opinion for Vueway® (gadopiclenol) for its use in pediatric patients under 2 years of age
54(8):475-484.Hao J, Pitrou C, Bourrinet P. A Comprehensive Overview of the Efficacy and Safety of Gadopiclenol: A New Contrast Agent for MRI of the CNS and Body. Invest Radiol 2024; 59(2):124-130.Kanal E, Maki JH, Schramm P, Marti-Bonmati L. Evolving Characteristics of Gadolinium-Based Contrast
More news about: Bracco Group
Dec 18, 2025, 17:03 ET Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
https://www.cohenandsteers.comSymbol: (NYSE: CNS)
More news about: Cohen & Steers, Inc.
Dec 18, 2025, 16:58 ET Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
https://www.cohenandsteers.comSymbol: (NYSE: CNS)
More news about: Cohen & Steers, Inc.
Dec 18, 2025, 16:43 ET Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
https://www.cohenandsteers.comSymbol: (NYSE: CNS)
More news about: Cohen & Steers, Inc.
Dec 18, 2025, 16:41 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
https://www.cohenandsteers.com/Symbol: (NYSE: CNS)
More news about: Cohen & Steers, Inc.
Dec 18, 2025, 16:32 ET Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
https://www.cohenandsteers.comSymbol: (NYSE: CNS)
More news about: Cohen & Steers, Inc.
Dec 18, 2025, 10:40 ET Neuraxpharm Goes Live with TraceLink MINT to Standardize Real‑Time Data Exchange Across Its Global Supply Chain Network
leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to
More news about: TraceLink Inc.
Dec 18, 2025, 10:22 ET Neuraxpharm Goes Live with TraceLink MINT to Standardize Real‑Time Data Exchange Across Its Global Supply Chain Network
leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to
More news about: TraceLink Inc.
Dec 18, 2025, 09:00 ET Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance
AI-powered drug discovery and biodefense company engages pharma on CNS programs amid rising deal activitySACRAMENTO, Calif., Dec. 18, 2025 /PRNewswire/ -- Lunai Bioworks Inc. (NASDAQ: LNAI), an AI-driven pharmaceutical
More news about: Lunai Bioworks Inc.
Dec 18, 2025, 08:05 ET Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
unmet medical needs using its patented iSPERSE™ technology. The Company's proprietary product pipeline includes treatments for central nervous system ("CNS") disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease ("COPD") and allergic bronchopulmonary aspergillosis
More news about: Pulmatrix Inc.
Dec 17, 2025, 16:00 ET Cohen & Steers Infrastructure Fund, Inc. Declares Distributions for January, February, and March 2026
https://www.cohenandsteers.com/Symbol: (NYSE: CNS)Symbol: (NYSE: UTF)
More news about: Cohen & Steers, Inc.
Dec 17, 2025, 11:30 ET New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
addictive behaviors.Respiratory Depression: Life threatening respiratory depression and death have occurred in association with buprenorphine. Warn patients of the potential danger of self-administration of benzodiazepines or other CNS depressants while under treatment with SUBLOCADE.Risk of Serious Injection Site Reactions: Likelihood of may increase with inadvertent
More news about: Indivior PLC
Dec 17, 2025, 02:00 ET KI-Optimierungstechnologie von Nota sorgt nach Erfolg im Nahen Osten die Verkehrsinnovation in Afrika voran
ITS-Technologie beschleunigt Expansion vom Nahen Osten nach AfrikaUnterzeichnung eines Technologie-Liefervertrags mit HANIL STM für das von LG CNS geleitete ITS-Projekt in NairobiSEOUL, Südkorea, 17. Dezember 2025
More news about: Nota AI
Dec 16, 2025, 17:36 ET Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Declares Year-End Capital Gain Distribution
https://www.cohenandsteers.com/ Symbol: (NYSE: CNS)About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income,
More news about: Cohen & Steers, Inc.